4 results match your criteria: "Hospital de Agudos Dr. Carlos G. Durand[Affiliation]"
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).
Mult Scler Relat Disord
September 2024
Centro Esclerosis Múltiple Buenos Aires (CEMBA)Buenos Aires, Argentina.
Article Synopsis
- Immunosuppressive therapies like azathioprine (AZA), mycophenolate mofetil (MMF), and rituximab (RTX) are used to prevent relapses in NMOSD, but response rates specifically in Argentina were previously unknown.
- A retrospective study analyzed 139 NMOSD patients from the RelevarEM registry, tracking their response to these treatments over a mean follow-up of 41.3 months, revealing that RTX had a significantly lower treatment failure rate compared to AZA and MMF.
- The study found treatment failures were 42.8% for AZA, 40% for MMF, and only 10.3% for RTX, indicating that higher efficacy treatments like RTX
[Pulmonary tumorlet associated with second neoplasia].
Medicina (B Aires)
July 2018
Sección Oncología Clínica, Hospital de Agudos Dr. Carlos G. Durand, Buenos Aires, Argentina.
Tumorlets are pulmonary neuroendocrine tumors smaller than 0.5 cm. They are benign and usually asymptomatic.
View Article and Find Full Text PDF[Aberrant immunophenotypes in acute leukemia in a Buenos Aires' hospital population].
Medicina (B Aires)
December 2013
Laboratorio de Inmunología, Unidad de Inmunología e Histocompatibilidad, Hospital de Agudos Dr. Carlos G. Durand, Buenos Aires, Argentina.
Multiparameter flow cytometry (MFC) has become the preferred method for the lineage assignment and maturational analysis of malignant cells in acute leukemias. Multiparametric immunophenotyping analysis allows the detection of aberrant antigen expression and the analysis of heterogeneity and clonality of malignant cells in leukemias. Our objectives were to analyze the membrane antigen expression and to evaluate if the aberrant phenotypes occurrence in blasts cells of patients with acute leukemia is useful in monitoring the response to the treatment.
View Article and Find Full Text PDF[Presence of B cell clones in acute myelomonocytic leukemia].
Medicina (B Aires)
March 2011
Laboratorio de Inmunología, Unidad de Inmunología, Hospital de Agudos Dr. Carlos G. Durand, Buenos Aires, Argentina.
The coexistence of acute myeloid leukemia and chronic lymphocytic leukemia in the same patient is rare. The majority of the cases correspond to patients that developed acute leukemia during the evolutionary course of a chronic lymphatic leukemia following treatment with chemotherapy drugs. We report a case of acute myelomonocytic leukemia concurrent with untreated B-cell chronic lymphocytic leukemia in which the use of flow cytometry analysis with a large panel of monoclonal antibodies, allowed the demonstration of different pathological populations and determine immunophenotyping patterns.
View Article and Find Full Text PDF